Form 4 Tracker
Christopher Gibson

Director · 14 filings · Latest: Jun 5, 2026

PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
RECURSION PHARMACEUTICALS, INC.
TickerOwnerRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Filing
RXRX
Christopher GibsonDirectorJan 20, 2026
Sale
$4.4740,000$178.8K913,839
RXRX
Gibson ChristopherJan 20, 2026
Proposed Sale
$4.4740,000$178.8K
RXRX
Gibson ChristopherJan 5, 2026
Proposed Sale
$4.2540,000$170.0K
RXRX
Gibson ChristopherDec 19, 2025
Proposed Sale
$4.5040,000$180.0K
RXRX
Gibson ChristopherDec 4, 2025
Proposed Sale
$4.6340,000$185.2K
RXRX
Gibson ChristopherNov 19, 2025
Proposed Sale
$4.1640,000$166.4K
RXRX
Gibson ChristopherNov 4, 2025
Proposed Sale
$5.2140,000$208.4K
RXRX
Gibson ChristopherOct 23, 2025
Proposed Sale
$5.70100,000$570.0K
RXRX
Gibson ChristopherOct 10, 2025
Proposed Sale
$6.04100,000$604.0K
RXRX
Gibson ChristopherSep 25, 2025
Proposed Sale
$4.76100,000$476.0K
RXRX
Gibson ChristopherSep 10, 2025
Proposed Sale
$4.71100,000$471.0K
RXRX
Gibson ChristopherAug 26, 2025
Proposed Sale
$4.84100,000$484.0K
RXRX
Gibson ChristopherAug 11, 2025
Proposed Sale
$5.28617,875$3.3M
RXRX
Gibson ChristopherMar 27, 2025
Proposed Sale
$6.04138,574$837.0K
RXRX
Gibson ChristopherMar 6, 2025
Proposed Sale
$6.3720,000$127.4K
RXRX
Gibson ChristopherMar 5, 2025
Proposed Sale
$6.5820,000$131.6K
RXRX
Gibson ChristopherFeb 6, 2025
Proposed Sale
$8.1220,000$162.4K
RXRX
Gibson ChristopherFeb 5, 2025
Proposed Sale
$7.6820,000$153.6K
RXRX
Gibson ChristopherJan 10, 2025
Proposed Sale
$7.0520,000$141.0K
RXRX
Gibson ChristopherJan 8, 2025
Proposed Sale
$7.3120,000$146.2K